IA‐0130, a novel 3‐(1,3‐diarylallylidene)oxindole derivative, alleviates ovarian cancer via inhibiting IL‐6/gp130/STAT3 signalling

Documenti analoghi

• Spatial Evaluation of Chironomus plumosus Distribution Around Agricultural Processing Facilities in Response to Climate Change
  di: Tae‐Hyeon Kim, et al.
  Pubblicazione: (2025)
• Association between metabolic dysfunction‐associated steatotic liver disease and myosteatosis measured by computed tomography
  di: Myung Jin Kim, et al.
  Pubblicazione: (2024)
• Real‐World Evidence of Long‐Term Dulaglutide Use: Sustained Glycemic and Weight Improvements Beyond Three Years
  di: Hwi Seung Kim, et al.
  Pubblicazione: (2025)
• CTCF ‐Binding Sites Demarcate Chromatin Domains Enriched With Histone H3K9me2 or H3K9me3 and Restrict the Spreading of These Modifications in Human Cells
  di: Kyung‐Ju Shin, et al.
  Pubblicazione: (2026)
• Efficacy and safety of combination therapy using SGLT2 and DPP4 inhibitors to treat type 2 diabetes: An updated systematic review and meta‐analysis with focus on an Asian subpopulation
  di: Myung Jin Kim, et al.
  Pubblicazione: (2025)